Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

China SXT Pharmaceuticals, Inc. SXTC

Full chart Compare
Set alert

Price alert · SXTC

All alert types
3.21 USD +0.33 (+11.45%)

Nov 4, 2026, 11:38 AM EST

2.84 Day range 3.40
2.71 52-week range 8,376,000.00
YTD
-100.00%
1 year
-100.00%

Financial health

Altman Z-Score

-0.98 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 3

Valuation

P/E -14.7×
FY 2017: 11042812×FY 2018: 11019624×FY 2019: 8428086×FY 2020: -129241×FY 2021: -925004×FY 2022: -97447×FY 2023: -30618×FY 2024: -44638×FY 2025: -3660×FY 2026: -14.7×
FY 2017 5y median -30618× FY 2026
P/S 85.2×
FY 2017: 2686593×FY 2018: 1868387×FY 2019: 1852923×FY 2020: 258312×FY 2021: 532404×FY 2022: 214850×FY 2023: 92170×FY 2024: 71677×FY 2025: 6946×FY 2026: 85.2×
FY 2017 5y median 71677× FY 2026
P/B 3.1×
FY 2017: 7078883×FY 2018: 3991346×FY 2019: 1169700×FY 2020: 141839×FY 2021: 159359×FY 2022: 34040×FY 2023: 12370×FY 2024: 9923×FY 2025: 783×FY 2026: 3.1×
FY 2017 5y median 9923× FY 2026
P/FCF -22.7×
FY 2017: 122872416×FY 2018: 15084106×FY 2019: -35030981×FY 2020: 2527492×FY 2021: -1804476×FY 2022: -229420×FY 2023: -1200003×FY 2024: -71431×FY 2025: -5151×FY 2026: -22.7×
FY 2017 5y median -71431× FY 2026
EV/EBITDA -9.2×
FY 2017: 7708115×FY 2018: 7444302×FY 2019: 6570122×FY 2020: -1321216×FY 2021: -1373677×FY 2022: -110685×FY 2023: -34893×FY 2024: -58791×FY 2025: -4693×FY 2026: -9.2×
FY 2017 5y median -34893× FY 2026
EV/Sales 59.9×
FY 2017: 2686593×FY 2018: 1868387×FY 2019: 1852922×FY 2020: 258312×FY 2021: 532401×FY 2022: 214848×FY 2023: 92163×FY 2024: 71672×FY 2025: 6936×FY 2026: 59.9×
FY 2017 5y median 71672× FY 2026
FCF Yield -4.4%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -0.0%FY 2020: 0.0%FY 2021: -0.0%FY 2022: -0.0%FY 2023: -0.0%FY 2024: -0.0%FY 2025: -0.0%FY 2026: -4.4%
FY 2017 5y median -0.0% FY 2026

Profitability

Gross Margin 17.1%
FY 2017: 47.4%FY 2018: 48.5%FY 2019: 65.8%FY 2020: 52.4%FY 2021: 59.4%FY 2022: 48.1%FY 2023: 21.6%FY 2024: 28.7%FY 2025: 21.1%FY 2026: 17.1%
FY 2017 5y median 21.6% FY 2026
Operating Margin -664.1%
FY 2017: 32.8%FY 2018: 23.3%FY 2019: 25.2%FY 2020: -26.0%FY 2021: -46.0%FY 2022: -199.4%FY 2023: -284.4%FY 2024: -130.4%FY 2025: -154.0%FY 2026: -664.1%
FY 2017 5y median -199.4% FY 2026
Net Margin -578.5%
FY 2017: 24.3%FY 2018: 16.9%FY 2019: 22.0%FY 2020: -199.3%FY 2021: -57.5%FY 2022: -220.4%FY 2023: -301.0%FY 2024: -160.7%FY 2025: -189.8%FY 2026: -578.5%
FY 2017 5y median -220.4% FY 2026
ROE -20.9%
FY 2017: 64.0%FY 2018: 36.1%FY 2019: 13.9%FY 2020: -109.4%FY 2021: -17.2%FY 2022: -34.9%FY 2023: -40.4%FY 2024: -22.2%FY 2025: -21.4%FY 2026: -20.9%
FY 2017 5y median -22.2% FY 2026
ROIC -23.1%
FY 2017: 55.8%FY 2018: 32.4%FY 2019: 10.9%FY 2020: -8.2%FY 2021: -12.8%FY 2022: -19.1%FY 2023: -30.4%FY 2024: -15.2%FY 2025: -16.3%FY 2026: -23.1%
FY 2017 5y median -19.1% FY 2026
ROA -17.9%
FY 2017: 21.8%FY 2018: 15.5%FY 2019: 8.8%FY 2020: -47.4%FY 2021: -8.0%FY 2022: -17.1%FY 2023: -20.1%FY 2024: -13.4%FY 2025: -15.2%FY 2026: -17.9%
FY 2017 5y median -17.1% FY 2026

Growth (YoY)

Revenue -38.4%
FY 2017: 31.3%FY 2018: 43.8%FY 2019: -0.1%FY 2020: -26.4%FY 2021: -7.5%FY 2022: -45.5%FY 2023: -24.2%FY 2024: -2.2%FY 2025: -9.7%FY 2026: -38.4%
FY 2017 FY 2026
Operating Income -165.7%
FY 2017: 666.1%FY 2018: 1.9%FY 2019: 8.4%FY 2020: -175.8%FY 2021: -63.8%FY 2022: -136.2%FY 2023: -8.1%FY 2024: 55.1%FY 2025: -6.6%FY 2026: -165.7%
FY 2017 FY 2026
EPS (diluted) -11.6%
FY 2017: -10.9%FY 2018: 0.2%FY 2019: 49.7%FY 2020: -655.9%FY 2021: 88.5%FY 2022: -44.4%FY 2023: 83.9%FY 2024: 83.9%FY 2025: -129.1%FY 2026: -11.6%
FY 2017 FY 2026
Free Cash Flow -71.1%
FY 2017: 24.9%FY 2018: 714.6%FY 2019: -142.7%FY 2020: 242.2%FY 2021: -367.2%FY 2022: -72.9%FY 2023: 93.8%FY 2024: -1177.8%FY 2025: -21.3%FY 2026: -71.1%
FY 2017 FY 2026

Financial Health

Current Ratio 7.9×
FY 2017: 1.4×FY 2018: 1.4×FY 2019: 2.5×FY 2020: 1.6×FY 2021: 1.3×FY 2022: 1.3×FY 2023: 1.3×FY 2024: 1.6×FY 2025: 3.5×FY 2026: 7.9×
FY 2017 5y median 1.6× FY 2026
Quick Ratio 7.3×
FY 2017: 1.1×FY 2018: 1.1×FY 2019: 2.3×FY 2020: 1.5×FY 2021: 1.2×FY 2022: 1.2×FY 2023: 1.3×FY 2024: 1.5×FY 2025: 3.4×FY 2026: 7.3×
FY 2017 5y median 1.5× FY 2026
Debt / Equity 0.0×
FY 2017: 0.2×FY 2018: 0.1×FY 2019: 0.3×FY 2020: 0.7×FY 2021: 0.0×FY 2022: 0.7×FY 2023: 0.3×FY 2024: 0.2×FY 2025: 0.1×FY 2026: 0.0×
FY 2017 5y median 0.2× FY 2026
Net Debt / EBITDA 3.9×
FY 2017: 0.1×FY 2018: -0.1×FY 2019: -3.2×FY 2020: 0.6×FY 2021: 7.2×FY 2022: 0.9×FY 2023: 2.6×FY 2024: 4.0×FY 2025: 6.7×FY 2026: 3.9×
FY 2017 5y median 3.9× FY 2026
Interest Coverage -113×
FY 2017: 39.7×FY 2018: 2095×FY 2019: 342×FY 2020: -0.4×FY 2021: -1.4×FY 2022: -141×FY 2023: -11.8×FY 2024: -4.6×FY 2025: -4.1×FY 2026: -113×
FY 2017 5y median -11.8× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-03-31